Cargando…

Deep radiomics-based fusion model for prediction of bevacizumab treatment response and outcome in patients with colorectal cancer liver metastases: a multicentre cohort study

BACKGROUND: Accurate tumour response prediction to targeted therapy allows for personalised conversion therapy for patients with unresectable colorectal cancer liver metastases (CRLM). In this study, we aimed to develop and validate a multi-modal deep learning model to predict the efficacy of bevaci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Shizhao, Sun, Dazhen, Mao, Wujian, Liu, Yu, Cen, Wei, Ye, Lechi, Liang, Fei, Xu, Jianmin, Shi, Hongcheng, Ji, Yuan, Wang, Lisheng, Chang, Wenju
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589780/ https://www.ncbi.nlm.nih.gov/pubmed/37869523 http://dx.doi.org/10.1016/j.eclinm.2023.102271

Ejemplares similares

Regorafenib in Refractory Metastatic Colorectal Cancer: A Multi-Center Retrospective Study
por: Xu, Donghao, et al.
Publicado: (2022)

Effect of Neoadjuvant Chemotherapy in Patients with Resectable Colorectal Liver Metastases
por: Zhu, Dexiang, et al.
Publicado: (2014)

Timing of Hepatectomy for Resectable Synchronous Colorectal Liver Metastases: For Whom Simultaneous Resection Is More Suitable - A Meta-Analysis
por: Feng, Qingyang, et al.
Publicado: (2014)

Anatomical resection improves relapse-free survival in colorectal liver metastases in patients with KRAS/NRAS/BRAF mutations or right-sided colon cancer: a retrospective cohort study
por: Chang, Wenju, et al.
Publicado: (2023)

Surgical resection of pulmonary metastases from colorectal cancer: 11 years of experiences
por: Cao, Guoquan, et al.
Publicado: (2017)

Determinants of Long-Term Outcome in Patients Undergoing Simultaneous Resection of Synchronous Colorectal Liver Metastases
por: Lin, Qi, et al.
Publicado: (2014)

Predicting EGFR mutation subtypes in lung adenocarcinoma using (18)F-FDG PET/CT radiomic features
por: Liu, Qiufang, et al.
Publicado: (2020)

Progression-Free Survival Prediction in Small Cell Lung Cancer Based on Radiomics Analysis of Contrast-Enhanced CT
por: Chen, Ningxin, et al.
Publicado: (2022)

Robotic versus open surgery for simultaneous resection of rectal cancer and liver metastases: a randomized controlled trial
por: Chang, Wenju, et al.
Publicado: (2023)

Transarterial chemoembolization alone or followed by bevacizumab for treatment of colorectal liver metastases
por: Fiorentini, Giammaria, et al.
Publicado: (2021)

Correlation Analysis of Gene and Radiomic Features in Colorectal Cancer Liver Metastases
por: Wang, Xuehu, et al.
Publicado: (2022)

Dynamic radiomics for predicting the efficacy of antiangiogenic therapy in colorectal liver metastases
por: Qu, Hui, et al.
Publicado: (2023)

Perfusion imaging of colorectal liver metastases treated with bevacizumab and stereotactic body radiotherapy
por: Detsky, Jay S., et al.
Publicado: (2018)

Distinguishing pure histopathological growth patterns of colorectal liver metastases on CT using deep learning and radiomics: a pilot study
por: Starmans, Martijn P. A., et al.
Publicado: (2021)

The Impact of Resampling and Denoising Deep Learning Algorithms on Radiomics in Brain Metastases MRI
por: Moummad, Ilyass, et al.
Publicado: (2021)

Impact of inter-reader contouring variability on textural radiomics of colorectal liver metastases
por: Rizzetto, Francesco, et al.
Publicado: (2020)

Colorectal liver metastases patients prognostic assessment: prospects and limits of radiomics and radiogenomics
por: Granata, Vincenza, et al.
Publicado: (2023)

FOLFOX6 and bevacizumab in non-optimally resectable liver metastases from colorectal cancer
por: Bertolini, F, et al.
Publicado: (2011)

Impact of Bevacizumab on parenchymal damage and functional recovery of the liver in patients with colorectal liver metastases
por: Volk, Andreas M., et al.
Publicado: (2016)

FOLFOXIRI plus bevacizumab in the treatment of metastatic colorectal cancer patients with unresectable liver metastases
por: Antoniotti, Carlotta, et al.
Publicado: (2022)

Bevacizumab treatment of meningeal melanoma metastases
por: Simonsen, Trude G., et al.
Publicado: (2020)

The m6A RNA Modification Quantity and the Prognostic Effect of Reader YTHDC2 in Colorectal Cancer
por: Liu, Tianyu, et al.
Publicado: (2022)

Differentiation of Glioblastoma and Brain Metastases by MRI-Based Oxygen Metabolomic Radiomics and Deep Learning
por: Stadlbauer, Andreas, et al.
Publicado: (2022)

Tumor classification of gastrointestinal liver metastases using CT-based radiomics and deep learning
por: Tharmaseelan, Hishan, et al.
Publicado: (2023)

Correction: Colorectal liver metastases patients prognostic assessment: prospects and limits of radiomics and radiogenomics
por: Granata, Vincenza, et al.
Publicado: (2023)

Differences in clinical characteristics and mutational pattern between synchronous and metachronous colorectal liver metastases
por: Zheng, Peng, et al.
Publicado: (2018)

Histopathologic evaluation of liver metastases from colorectal cancer in patients treated with FOLFOXIRI plus bevacizumab
por: Loupakis, F, et al.
Publicado: (2013)

Notch-Jagged1 signaling and response to bevacizumab therapy in advanced colorectal cancer: A glance to radiomics or back to physiopathology?
por: Negri, Francesca, et al.
Publicado: (2023)

Multicentric validation of radiomics findings: challenges and opportunities
por: Hatt, Mathieu, et al.
Publicado: (2019)

Predictive And Prognostic Value Of Hepatic Steatosis In Conversion Therapy For Colorectal Liver-limited Metastases: A Propensity Score Matching Analysis
por: Jian, Mi, et al.
Publicado: (2019)

Multicentre study of perioperative versus adjuvant chemotherapy for resectable colorectal liver metastases
por: Allard, M.‐A., et al.
Publicado: (2019)

Radiomics artificial intelligence modelling for prediction of local control for colorectal liver metastases treated with radiotherapy
por: Hu, Ricky, et al.
Publicado: (2022)

Development and Validation of a Radiomics Nomogram for Liver Metastases Originating from Gastric and Colorectal Cancer
por: Li, Yuying, et al.
Publicado: (2023)

Comment on ‘Histopathologic evaluation of liver metastases from colorectal cancer in patients treated with FOLFOXIRI plus bevacizumab'
por: Bibeau, F, et al.
Publicado: (2013)

Bevacizumab plus FOLFOX or FOLFIRI regimens on patients with unresectable liver-only metastases of metastatic colorectal cancer
por: Mehrzad, Valiollah, et al.
Publicado: (2016)

Bevacizumab with preoperative chemotherapy versus preoperative chemotherapy alone for colorectal cancer liver metastases: a retrospective cohort study
por: Lu, Zhen-Hai, et al.
Publicado: (2016)

Quantitative Prediction of Microsatellite Instability in Colorectal Cancer With Preoperative PET/CT-Based Radiomics
por: Li, Jiaru, et al.
Publicado: (2021)

Radiomics of liver MRI predict metastases in mice
por: Becker, Anton S., et al.
Publicado: (2018)

Radiomics of Liver Metastases: A Systematic Review
por: Fiz, Francesco, et al.
Publicado: (2020)

PET/MRI Radiomics in Patients With Brain Metastases
por: Lohmann, Philipp, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5f50vls6jjgi5vjsn58o3ctnta